132 related articles for article (PubMed ID: 11130669)
1. Anti-leishmanial activity of neolignans from Virola species and synthetic analogues.
Barata LE; Santos LS; Ferri PH; Phillipson JD; Paine A; Croft SL
Phytochemistry; 2000 Nov; 55(6):589-95. PubMed ID: 11130669
[TBL] [Abstract][Full Text] [Related]
2. Leishmania amazonensis and Leishmania chagasi: In vitro leishmanicide activity of Virola surinamensis (rol.) warb.
Veiga A; Albuquerque K; Corrêa ME; Brigido H; Silva E Silva J; Campos M; Silveira F; Santos L; Dolabela M
Exp Parasitol; 2017 Apr; 175():68-73. PubMed ID: 28174103
[TBL] [Abstract][Full Text] [Related]
3. Asymmetric synthesis and anti-protozoal activity of the 8,4'-oxyneolignans virolin, surinamensin and analogues.
Rye CE; Barker D
Eur J Med Chem; 2013 Feb; 60():240-8. PubMed ID: 23313632
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationship of antileishmanials neolignan analogues.
Aveniente M; Pinto EF; Santos LS; Rossi-Bergmann B; Barata LE
Bioorg Med Chem; 2007 Dec; 15(23):7337-43. PubMed ID: 17888668
[TBL] [Abstract][Full Text] [Related]
5. A parasite rescue and transformation assay for antileishmanial screening against intracellular Leishmania donovani amastigotes in THP1 human acute monocytic leukemia cell line.
Jain SK; Sahu R; Walker LA; Tekwani BL
J Vis Exp; 2012 Dec; (70):. PubMed ID: 23299097
[TBL] [Abstract][Full Text] [Related]
6. The lignan niranthin poisons Leishmania donovani topoisomerase IB and favours a Th1 immune response in mice.
Chowdhury S; Mukherjee T; Mukhopadhyay R; Mukherjee B; Sengupta S; Chattopadhyay S; Jaisankar P; Roy S; Majumder HK
EMBO Mol Med; 2012 Oct; 4(10):1126-43. PubMed ID: 23027614
[TBL] [Abstract][Full Text] [Related]
7. Indolylquinoline derivatives are cytotoxic to Leishmania donovani promastigotes and amastigotes in vitro and are effective in treating murine visceral leishmaniasis.
Chakrabarti G; Basu A; Manna PP; Mahato SB; Mandal NB; Bandyopadhyay S
J Antimicrob Chemother; 1999 Mar; 43(3):359-66. PubMed ID: 10223591
[TBL] [Abstract][Full Text] [Related]
8. Discovery of novel hit compounds with broad activity against visceral and cutaneous Leishmania species by comparative phenotypic screening.
Lamotte S; Aulner N; Späth GF; Prina E
Sci Rep; 2019 Jan; 9(1):438. PubMed ID: 30679614
[TBL] [Abstract][Full Text] [Related]
9. 15d-Prostaglandin J2 induced reactive oxygen species-mediated apoptosis during experimental visceral leishmaniasis.
Vishwakarma P; Parmar N; Yadav PK; Chandrakar P; Kar S
J Mol Med (Berl); 2016 Jun; 94(6):695-710. PubMed ID: 26830627
[TBL] [Abstract][Full Text] [Related]
10. A semi-synthetic neolignan derivative from dihydrodieugenol B selectively affects the bioenergetic system of Leishmania infantum and inhibits cell division.
Amaral M; de Sousa FS; Silva TAC; Junior AJG; Taniwaki NN; Johns DM; Lago JHG; Anderson EA; Tempone AG
Sci Rep; 2019 Apr; 9(1):6114. PubMed ID: 30992481
[TBL] [Abstract][Full Text] [Related]
11. Immunomodulatory and Antileishmanial Activity of Phenylpropanoid Dimers Isolated from Nectandra leucantha.
da Costa-Silva TA; Grecco SS; de Sousa FS; Lago JH; Martins EG; Terrazas CA; Varikuti S; Owens KL; Beverley SM; Satoskar AR; Tempone AG
J Nat Prod; 2015 Apr; 78(4):653-7. PubMed ID: 25835647
[TBL] [Abstract][Full Text] [Related]
12. Flavonoids and lignans from Virola surinamensis twigs and their in vitro activity against Trypanosoma cruzi.
Lopes NP; Chicaro P; Kato MJ; Albuquerque S; Yoshida M
Planta Med; 1998 Oct; 64(7):667-8. PubMed ID: 9810278
[TBL] [Abstract][Full Text] [Related]
13. Leishmanicidal activity assessment of olive tree extracts.
Kyriazis JD; Aligiannis N; Polychronopoulos P; Skaltsounis AL; Dotsika E
Phytomedicine; 2013 Feb; 20(3-4):275-81. PubMed ID: 23273752
[TBL] [Abstract][Full Text] [Related]
14. Use of in vitro method to assess different brands of anti-leishmanial drugs.
Arora SK; Sinha R; Sehgal S
Med Microbiol Immunol; 1991; 180(1):21-7. PubMed ID: 2056963
[TBL] [Abstract][Full Text] [Related]
15. Effect of allicin on promastigotes and intracellular amastigotes of Leishmania donovani and L. infantum.
Jesús Corral-Caridad M; Moreno I; Toraño A; Domínguez M; Alunda JM
Exp Parasitol; 2012 Dec; 132(4):475-82. PubMed ID: 22995646
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo antileishmanial efficacy of a new nitrilquinoline against Leishmania donovani.
Nakayama H; Desrivot J; Bories C; Franck X; Figadère B; Hocquemiller R; Fournet A; Loiseau PM
Biomed Pharmacother; 2007; 61(2-3):186-8. PubMed ID: 17360145
[TBL] [Abstract][Full Text] [Related]
17. Using a non-image-based medium-throughput assay for screening compounds targeting N-myristoylation in intracellular Leishmania amastigotes.
Paape D; Bell AS; Heal WP; Hutton JA; Leatherbarrow RJ; Tate EW; Smith DF
PLoS Negl Trop Dis; 2014 Dec; 8(12):e3363. PubMed ID: 25522361
[TBL] [Abstract][Full Text] [Related]
18. Arylanthranilodinitriles: a new biaryl class of antileishmanial agents.
Singh FV; Vatsyayan R; Roy U; Goel A
Bioorg Med Chem Lett; 2006 May; 16(10):2734-7. PubMed ID: 16503140
[TBL] [Abstract][Full Text] [Related]
19. Effect of isoxazole derivatives of tetrahydrofuran neolignans on intracellular amastigotes of Leishmania (Leishmania) amazonensis: A structure-activity relationship comparative study with triazole-neolignan-based compounds.
das Neves AR; Trefzger OS; Barbosa NV; Honorato AM; Carvalho DB; Moslaves IS; Kadri MCT; Yoshida NC; Kato MJ; Arruda CCP; Baroni ACM
Chem Biol Drug Des; 2019 Dec; 94(6):2004-2012. PubMed ID: 31444858
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and pharmacological evaluation of mono-arylimidamides as antileishmanial agents.
Zhu X; Farahat AA; Mattamana M; Joice A; Pandharkar T; Holt E; Banerjee M; Gragg JL; Hu L; Kumar A; Yang S; Wang MZ; Boykin DW; Werbovetz KA
Bioorg Med Chem Lett; 2016 May; 26(10):2551-2556. PubMed ID: 27048943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
